[HTML][HTML] Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review
C Gutiérrez Villegas, M Paz-Zulueta… - Health Economics …, 2021 - Springer
Abstract Background Chronic Obstructive Pulmonary Disease (COPD) is a treatable disease
with a high prevalence, and high morbidity associated with significant socioeconomic costs …
with a high prevalence, and high morbidity associated with significant socioeconomic costs …
Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review.
CG Villegas, M Paz-Zulueta… - Health Economics …, 2021 - go.gale.com
Background Chronic Obstructive Pulmonary Disease (COPD) is a treatable disease with a
high prevalence, and high morbidity associated with significant socioeconomic costs …
high prevalence, and high morbidity associated with significant socioeconomic costs …
Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review
CG Villegas, M Paz-Zulueta, M Herrero-Montes… - Health Economics …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Chronic Obstructive Pulmonary Disease (COPD) is a treatable disease with a high …
Chronic Obstructive Pulmonary Disease (COPD) is a treatable disease with a high …
Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review
GV Celia, PZ María, M Herrero-Montes… - Health Economics …, 2021 - search.proquest.com
Background Chronic Obstructive Pulmonary Disease (COPD) is a treatable disease with a
high prevalence, and high morbidity associated with significant socioeconomic costs …
high prevalence, and high morbidity associated with significant socioeconomic costs …
[HTML][HTML] Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review
C Gutiérrez Villegas… - Health …, 2021 - healtheconomicsreview …
Chronic Obstructive Pulmonary Disease (COPD) is a treatable disease with a high
prevalence, and high morbidity associated with significant socioeconomic costs. To carry out …
prevalence, and high morbidity associated with significant socioeconomic costs. To carry out …
Cost analysis of Chronic Obstructive Pulmonary Disease (COPD): A systematic review
C Gutiérrez Villegas, M Paz-Zulueta… - Health Economics …, 2021 - econstor.eu
Background: Chronic Obstructive Pulmonary Disease (COPD) is a treatable disease with a
high prevalence, and high morbidity associated with significant socioeconomic costs …
high prevalence, and high morbidity associated with significant socioeconomic costs …
Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review.
C Gutiérrez Villegas, M Paz-Zulueta, M Herrero-Montes… - 2021 - cabidigitallibrary.org
Abstract Background: Chronic Obstructive Pulmonary Disease (COPD) is a treatable
disease with a high prevalence, and high morbidity associated with significant …
disease with a high prevalence, and high morbidity associated with significant …
Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review
C Gutiérrez Villegas, M Paz Zulueta, M Herrero Montes… - 2021 - repositorio.unican.es
Background Chronic Obstructive Pulmonary Disease (COPD) is a treatable disease with a
high prevalence, and high morbidity associated with significant socioeconomic costs …
high prevalence, and high morbidity associated with significant socioeconomic costs …
[HTML][HTML] Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review
CG Villegas, M Paz-Zulueta… - Health Economics …, 2021 - ncbi.nlm.nih.gov
Background Chronic Obstructive Pulmonary Disease (COPD) is a treatable disease with a
high prevalence, and high morbidity associated with significant socioeconomic costs …
high prevalence, and high morbidity associated with significant socioeconomic costs …
Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review
CG Villegas, M Paz-Zulueta… - Health Economics …, 2021 - econpapers.repec.org
Abstract Background Chronic Obstructive Pulmonary Disease (COPD) is a treatable disease
with a high prevalence, and high morbidity associated with significant socioeconomic costs …
with a high prevalence, and high morbidity associated with significant socioeconomic costs …